PUBLISHED FOR OPPOSITION
on 19 Nov 2024
Last Applicant/ Owned by
FI-02180 Espoo
FI
Serial Number
79358529 filed on 19th May 2022
Registration Number
N/A
Correspondent Address
ROGER H. BORA
ROGER H. BORA THOMPSON HINE LLP
AUSTIN LANDING, DISCOVERY PLACE BUILDING
DAYTON, OH 45342
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
MEDIX BIOCHEMICA
Medical and scientific research; pharmaceutical research and development; development of antibodies for others; antibody research and development services; development of assays for diagnostic purposes; medical laboratories; conducting clinical trials; scientific research consulting services in the field of medical and health care technology; medical and pharmacological research; providing of info Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing medical information, consultation and advisory services; medical consulting services in the field of diagnostics; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; providing medical information through a website; medical diagnostic testing and reporting services; tissue typing services in the nature of blood testing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research; pharmaceutical research and development; development of antibodies for others; antibody research and development services; development of assays for diagnostic purposes; medical laboratories; conducting clinical trials; scientific research consulting services in the field of medical and health care technology; medical and pharmacological research; providing of information and data relating to medical research and development; product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; monoclonal antibody research and development services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Medical testing devices utilizing immunological methods, in the form of kits primarily comprised of test strips capable of visual or instrument read out of test results, buffer tubes, medical specimen collection loops and vials, for use in testing of blood, plasma, serum, and other bodily fluids, and also including cotton swabs and pads for medical purposes; medical diagnostic instruments for in vitro diagnostic testing and in vitro analysis utilizing immunological methods for use in the field of immunology, anesthesia, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics, radiology, radiation, oncology, and surgery; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for medical use for use in in vitro diagnostic testing procedures, cardiovascular diagnosis and screening, diabetes monitoring and diagnosis, pregnancy monitoring, monitoring and diagnosing metabolic functions, detecting, screening and monitoring infectious diseases, inflammatory diseases, skin disorders, thyroid diseases and cancer; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for blood analysis, urine analysis, fecal analysis, saliva analysis, analysis of oral fluids, analysis of amniotic fluids, analysis of cervicospinal fluid, analysis of ascites, analysis of pleural fluids, analysis of exudate, analysis of cervical, vaginal and cervico-vaginal secretions; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use comprised of collection pads or swabs, collection loops or vials, test strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for analysing oral fluid, urine, feces, amniotic fluid, vaginal secretions, cervical secretions, cervico-vaginal secretions, finger stick or venipuncture whole blood, plasma, serum, exudate, skin, cervicospinal fluid, ascites, pleural fluids, other bodily fluids and specimens; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for use in detecting antibodies, antigen, viruses, bacteria and other pathogens, disease markers and metabolites, fecal occult blood, hormones, vitamins, proteins, nucleic acids, toxins, drugs and their metabolites, drugs of abuse and chemicals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical reagents for medical or veterinary purposes; medical diagnostic reagents; veterinary diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for diagnostic purposes; monoclonal antibodies for medical and diagnostic use; pregnancy and fertility test kits for home and medical use; medical diagnostic test strips for home and medical use for use in the fields of immunology, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics and oncology; diagnostic preparations for medical use; reagent media for medical diagnostic purposes; medical immunological diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer; monoclonal antibodies for use in disease testing; leukocyte antibodies for use in disease testing; cytokines and chemokines for use in disease testing; adhesion molecules for use in disease testing; endothelial cells for medical use; progenitor cells for medical use; medical diagnostic reagents and assays for detecting apoptosis; medical diagnostic reagents for cellular transduction; stem cells for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents for use in scientific and medical research; diagnostic preparations for medical research; reagent media for medical research; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for scientific or research use; antibodies for use in scientific and medical research in the nature of mononuclean antibodies; assays for research purposes; buffer solutions for use in analytical chemistry; control reagents for research purposes for use with scientific apparatus and instruments; protein labelling kits comprising reagents for use in scientific and medical research; assay kits consisting of chemical reagents for scientific and medical research; assay kits consisting of biological reagents for scientific and medical research; protein in raw material form for scientific and medical research; proteins in raw material form for scientific and medical research for detecting antibodies; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; chemicals for use in biotechnological manufacturing processes and product development; nucleotides for scientific and research use; proteins for use in manufacture; reagent medium for medical research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Manufacturing of diagnostic preparations and reagent medium to order for medical use and medical research and non-medical purposes; manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, diagnostics, health care products and medical products; treatment of materials, namely, pharmaceutical, diagnostic and chemical products and their components used in the manufacture of pharmaceuticals, biopharmaceuticals, diagnostic preparations, reagent media, test kits, testing apparatus and instruments; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, diagnostic preparations and reagent medium
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79358529
Mark Type
No Service Mark
Attorney Docket Number
No 079497.00257
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 13th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 10th Oct 2024 | EXPARTE APPEAL TERMINATED |
| 10th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th Jun 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 07th Jun 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 07th Jun 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 28th Mar 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 28th Mar 2024 | EX PARTE APPEAL-INSTITUTED |